In sepsis-induced myocardial injury, GSK-3β inhibition blocks NF-κB activation by downregulating β-catenin-mediated FOXO3a expression, thereby reducing apoptosis and inflammatory responses in rat cardiomyocytes [32]. The gene discussed is FOXO3; the disease is Sepsis.